VILJŪRIS vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 212,224 | 189,062 | 225,942 | 228,277 | 233,994 | 205,638 | 201,293 | 189,700 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -17,709 | -13,514 | 58,059 | 61,344 | 72,442 | 80,272 | 80,112 | 83,219 |
| Equity | -223,769 | -237,282 | -179,223 | -120,649 | -48,207 | 32,065 | 112,177 | 195,396 |
| Liabilities | 836,474 | 764,161 | 700,899 | 612,337 | 492,700 | 386,938 | 284,725 | 196,508 |
| Non-current assets | 539,090 | 425,625 | 406,647 | 367,923 | 328,979 | 288,583 | 249,677 | 261,101 |
| Current assets | 91,271 | 115,092 | 129,055 | 135,419 | 123,915 | 139,954 | 154,807 | 137,880 |
| Total assets | 630,361 | 540,717 | 535,702 | 503,342 | 452,894 | 428,537 | 404,484 | 398,981 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 45,821 | 47,150 | 43,338 |
| Social insurance contributions | - | - | - | - | - | 9,407 | 10,969 | 12,634 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -7.6% | -10.9% | +19.5% | +1.0% | +2.5% | -12.1% | -2.1% | -5.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.8% | -2.5% | 10.8% | 12.2% | 16.0% | 18.7% | 19.8% | 20.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | 250.3% | 71.4% | 42.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.3% | -7.1% | 25.7% | 26.9% | 31.0% | 39.0% | 39.8% | 43.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 12.1 | 2.5 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 42,445 | 37,812 | 45,188 | 45,655 | 46,799 | 49,353 | 50,323 | 38,583 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VILJŪRIS vaistinė - Social security debts
The company had no debts to Sodra
VILJŪRIS vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-01 | 2026-06-05 | 0.74 |
| 2026-03-02 | 2026-03-17 | 0.69 |
| 2026-01-29 | 2026-02-16 | 0.54 |
| 2025-08-01 | 2025-08-11 | 2.25 |
| 2025-07-28 | 2025-07-28 | 2761.0 |
| 2025-05-19 | 2025-05-20 | 1.16 |
| 2025-05-17 | 2025-05-18 | 0.88 |
| 2025-03-28 | 2025-04-25 | 0.41 |
| 2025-01-01 | 2025-01-27 | 1.26 |
| 2024-12-30 | 2024-12-30 | 1543.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VILJURIS, UAB, company code 185318062, is a Private Limited Liability Company operating in the retail sale of pharmaceutical products. In 2025, it generated revenue of €189.7K and net profit of €83.2K, corresponding to a profit margin of 43.9%. Revenue declined by 5.8% year on year and by 7.8% over two years, while profit remained resilient and increased slightly compared with 2024. The 2023–2025 trajectory shows a gradual contraction in sales from €205.6K to €201.3K and then €189.7K, alongside net profit staying in a narrow range of about €80K–€83K. The balance sheet strengthened in 2025: equity rose to €195.4K from €112.2K in 2024, while liabilities decreased to €196.5K from €284.7K. Total assets were €399.0K, with long-term assets of €261.1K and short-term assets of €137.9K. Key ratios indicate solid profitability and moderate leverage, with ROE at 42.6%, ROA at 20.9%, debt-to-equity at 1.01, and asset turnover at 0.48x. Revenue per employee was €47.4K.